Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Kuldeep K, Roy"'
Publikováno v:
Frontiers in Drug Discovery, Vol 4 (2024)
Externí odkaz:
https://doaj.org/article/f4602245264e4e4e9022766d28e88db0
Publikováno v:
Life, Vol 13, Iss 3, p 700 (2023)
The endocannabinoid system consists of several phytocannabinoids, cannabinoid receptors, and enzymes that aid in numerous steps necessary to manifest any pharmacological activity. It is well known that the endocannabinoid system inhibits the pathogen
Externí odkaz:
https://doaj.org/article/ad525ba4d00d4e7693cf083d99fc3ef6
Publikováno v:
Journal of Biomolecular Structure and Dynamics. :1-10
There is currently no drug available to treat mosquito-borne dengue. The C-terminal RNA-dependent RNA polymerase (RdRp) domain in the non-structural type 5 (NS5) protein of the dengue virus (DENV) is essential for viral RNA synthesis and replication,
Autor:
Siddharth K. Tripathi, Qin Feng, Li Liu, David E. Levin, Kuldeep K. Roy, Robert J. Doerksen, Scott R. Baerson, Xiaomin Shi, Xuewen Pan, Wen-Hui Xu, Xing-Cong Li, Alice M. Clark, Ameeta K. Agarwal
Publikováno v:
mSphere, Vol 5, Iss 1 (2020)
ABSTRACT The cell wall-targeting echinocandin antifungals, although potent and well tolerated, are inadequate in treating fungal infections due to their narrow spectrum of activity and their propensity to induce pathogen resistance. A promising strat
Externí odkaz:
https://doaj.org/article/5135f27089314ab884d2181bb1856ca4
Autor:
Mrinalkanti Kundu, Aditi Dutta, Kuldeep K. Roy, Sajal K. Mal, Shouvik Karmakar, Aritra Mandal, Susanta K. Mondal, Sanjay Kumar, Soumya Saha, Subhankar Pradhan, Ratul Sarkar, Monali Chakrabarti, Pradip K. Malik, Manish Banerjee
Publikováno v:
Chemical Biology & Drug Design. 101:690-695
Autor:
Ashis Roy, Tonmoy Sarkar, Sebak Datta, Arup Maiti, Monali Chakrabarti, Trisha Mondal, Chaitali Mondal, Apurba Banerjee, Subhasis Roy, Soumen Mukherjee, Pragati Muley, Sabyasachi Chakraborty, Manish Banerjee, Mrinalkanti Kundu, Kuldeep K. Roy
Publikováno v:
Chemical Biology & Drug Design. 99:496-503
Inhibition of extracellular secreted enzyme autotaxin (ATX) represents an attractive strategy for the development of new therapeutics to treat various diseases and a few inhibitors entered in clinical trials. We herein describe structure-based design
Publikováno v:
Materials Today: Proceedings. 57:300-306
Publikováno v:
Materials Today: Proceedings. 57:44-48
Publikováno v:
Medical & Biological Engineering & Computing. 59:2397-2408
The ubiquitous antimicrobial peptides (AMPs), with a broad range of antimicrobial activities, represent a great promise for combating the multi-drug resistant infections. In this study, using a large and diverse set of AMPs (2638) and non-AMPs (3700)
Autor:
Mrinalkanti, Kundu, Aditi, Dutta, Kuldeep K, Roy, Sajal K, Mal, Shouvik, Karmakar, Aritra, Mandal, Susanta K, Mondal, Sanjay, Kumar, Soumya, Saha, Subhankar, Pradhan, Ratul, Sarkar, Monali, Chakrabarti, Pradip K, Malik, Manish, Banerjee
Publikováno v:
Chemical biologydrug designREFERENCES.
Malaria continues to be a significant public health problem threatened by the emergence and spread of resistance to artemisinin-based combination therapies and marked half a million deaths in 2016. A new imidazopyridine chemotype has been envisaged t